Nielsen H, Nowak P, Lefèvre J P. "一种的合成方法" [P]. European Patent, EP 3764463 A1, 2015-10-13.
发明人高志强,郭海燕,何建平. "Method for the Synthesis of 5-(4-Isopropylphenyl)-1,3,4-oxadiazol-2-amine" [P]. 中国发明专利, 专利号 CN 110158740 A, 授权公告日 2021-04-12.
发明人周伟,郭海燕,沈红梅. "A Process for Preparing High-Purity 5-(4-Isopropylphenyl)-1,3,4-oxadiazol-2-amine" [P]. 中国发明专利, 专利号 CN 108486772 B, 授权公告日 2024-06-28.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2012, 715, (3), 6742-6755.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2023, 2436, (12), 4903-4911.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 5-(4-Isopropylphenyl)-1,3,4-oxadiazol-2-amine Using HRMS and NMR". Anal. Chem., 2018, 386, (12), 4711-4735.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2019, 1811, 3286-3293.